Aarkstore Enterprise-Cancer pain – pipeline review, h2 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Cancer Pain – Pipeline Review, H2 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Cancer Pain - Pipeline Review, H2 2012, provides an
overview of the indication’s therapeutic pipeline. This report provides information
on the therapeutic development for Cancer Pain, complete with latest updates, and
special features on late-stage and discontinued projects. It also reviews key players
involved in the therapeutic development for Cancer Pain. Cancer Pain - Pipeline
Review, Half Year is built using data and information sourced from Global Markets
Direct’s proprietary databases, Company/University websites, SEC filings, investor
presentations and featured press releases from company/university sites and
industry-specific third party sources, put together by Global Markets Direct’s team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Cancer Pain.
- A review of the Cancer Pain products under development by companies and
universities/research institutes based on information derived from company and
industry-specific sources.

2. Reasons to buy
- Identify and understand important and diverse types of therapeutics under
development for Cancer Pain.
- Identify emerging players with potentially strong product portfolio and design
effective counter-strategies to gain competitive advantage.
Table of contents:
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Cancer Pain Overview 10
Therapeutics Development 11
An Overview of Pipeline Products for Cancer Pain 11
Cancer Pain Therapeutics under Development by Companies 13
Cancer Pain Therapeutics under Investigation by Universities/Institutes 17
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Discovery and Pre-Clinical Stage Products 21
Comparative Analysis 21
Cancer Pain Therapeutics – Products under Development by Companies 22
Cancer Pain Therapeutics – Products under Investigation by Universities/Institutes
23
Companies Involved in Cancer Pain Therapeutics Development 24
Johnson & Johnson 24
BioDelivery Sciences International, Inc. 25
List of Figures

3. List of Tables are also include.
For more related Reports Plz follow The link:
Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Neutropenia – Pipeline Review, H2 2012
Amyloidosis – Pipeline Review, H2 2012
Human Papillomavirus Infections – Pipeline Review, H2 2012
Cancer Pain – Pipeline Review, H2 2012
Dengue – Pipeline Review, H2 2012
Gastrointestinal Tract Cancer – Pipeline Review, H2 2012
Diabetes – Pipeline Review, H2 2012
Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012
Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review,
H2 2012
Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012
Malaria – Pipeline Review, H2 2012

4. Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review,
H2 2012
Dermatitis – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1
For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com